Abstract
Current standard treatment for locally advanced but resectable (stages III and IV and selected stage II) head and neck cancer includes surgery combined with preoperative or postoperative radiation therapy or radiation therapy alone or combined with a neck dissection with surgery reserved for salvage. Chemotherapy may be added. However, other than a neoadjuvant role for organ preservation in advanced larynx or pyriform sinus cancer and a concomitant and maintenance role in advanced nasopharyngeal cancer, the role for chemotherapy remains to be defined (1–3). Despite advances made in recent years with combined modality therapy, local and regional recurrence rates remain unacceptably high (20–60%), and 5-year survival rates remain disappointingly low (30–60%).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
The Department of Veterans Affairs Laryngeal Cancer Study Group, Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer, N. Engl. J. Med., 324 (1991) 1675–1690.
Lefebrre JL, Chevalier D, Luboinski B, et al. Larynx preservation in piriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer Phase III Trial, J. Natl. Cancer Inst., 88 (1996) 890–899.
Al-Sarraf M, LeBlanc M, Giri PGS, et al. Improved overall survival with chemoradiotherapy (CT-RT) vs radiotherapy (RT) in patients (pts) with locally advanced nasopharyngeal Cancer (NPC). Preliminary results of Intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) Randomized Study, Fourth International Conference on Head and Neck Cancer, Toronto, 1996, p. 118.
Kramer S, Gelber RD, Snow JB, et al. Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73–03 of the Radiation Therapy Oncology Group, Head Neck Surg., 10 (1987) 19–30.
Peters LJ, Goepfert H, Ang KK, et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial, Int. J. Radiat. Oncol. Biol. Phys., 26 (1993) 3–11.
Tupchong L, Scott CB, Blitzer PH, et al. Randomized Study of Preoperative Versus Postoperative Radiation Therapy in Advanced Head and Neck Carcinoma: Long-Term Follow-Up of RTOG Study 73–03, Int. J. Radiat. Oncol. Biol. Phys., 20 (1991) 21–28.
Ang KK, Trotti A, Garden AS, et al. Importance of Overall Time Factor in Postoperative Radiation Therapy, Proceedings Fourth International Conference on Head and Neck Cancer, Toronto, 1996, pp. 231–235.
Laramore GE, Scott CB, Al-Sarraf M, et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034, Int. J. Radiat. Oncol. Biol. Phys., 23 (1992) 705–713.
Adjuvant Chemotherapy for Advanced Head and Neck Squamous Carcinoma, Final Report of the Head and Neck Contracts Program. Cancer, 60 (1987) 301–311.
Schuller DE, Metch B, and Stein DW. Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest Oncology Group, Laryngoscope, 98 (1988) 1205–1211.
Holoye PY, Grossman TW, Toohill RJ, et al. Randomized study of adjuvant chemotherapy for head and neck cancer, Otolarngol. Head Neck Surg., 93 (1985) 712–717.
Olsen KD, Caruso M, Foote RL, et al. Histopathologic predictors of recurrence after neck dissection in patients with lymph node involvement, Arch. Otolaryngol. Head Neck Surg., 120 (1994) 1370–1374.
Chen TY, Emrich LJ, and Driscoll DL. The clinical significance of pathological findings in surgically resected margins of the primary tumor in head and neck carcinoma, Int. J. Radiat. Oncol. Biol. Phys., 13 (1987) 833–837.
Scholl P, Byers RM, Batsakis JG, et al. Microscopic cut-through of cancer in the surgical treatment of squamous carcinoma of the tongue. Prognostic and therapeutic implications, Ann. J. Surg., 152 (1986) 354–360.
Looser KG, Shah JP, and Strong EW. The significance of “positive” margins in surgically resected epidermoid carcinomas, Head Neck Surg., 1 (1978) 107–111.
Zbaeren P and Lehmann W. Frequency and sites of distant metastases in head and neck squamous cell carcinoma, Arch. Otolaryngol. Head Neck Surg., 113 (1987) 762–764.
Huang D, Johnson CR, Schmidt-Ullrich RK, et al. Incompletely resected advanced squamous cell carcinoma of the head and neck: the effectiveness of adjuvant vs salvage radiotherapy, Radiother. Oncol., 24 (1992) 87–93.
Byers RM, Bland KI, Borlase B, et al. The prognostic and therapeutic value of frozen section determinations in the surgical treatment of squamous carcinoma of the head and neck, Ann. J. Surg., 136 (1978) 525–528.
Laramore GE, Scott CB, Schuller DE, et al. Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: a comparative study using the Intergroup Study 0034 and the Radiation Therapy Oncology Group Head and Neck Database, Int. J. Radiat. Oncol. Biol. Phys., 27 (1993) 1011–1016.
Zelefsky MJ, Harrison LB, Fass DE, et al. Postoperative radiation therapy for squamous cell carcinomas of the oral cavity and oropharynx: impact of therapy on patients with positive surgical margins, Int. J. Radiat. Oncol. Biol. Phys., 25 (1992) 17–21.
Ahmad K, Cordoba RB, and Fayos JV. Squamous cell carcinoma of the maxillary sinus, Arch. Otolaryngol., 107 (1981) 48–51.
Beale FA and Garrett PG. Cancer of the paranasal sinuses with particular reference to maxillary sinus cancer, J. Otolaryngol., 12 (1983) 377–382.
Kondo M, Ogawa K, Inuyama Y, et al. Prognostic factors influencing relapse of squamous cell carcinoma of the maxillary sinus, Cancer, 55 (1985) 190–196.
Korzeniowski S, Reinfuss M, and Skolyszewski J. The evaluation of radiotherapy after incomplete surgery in patients with carcinoma of the maxillary sinus, Int. J. Radiat. Oncol. Biol. Phys., 11 (1985) 505–509.
Tsujii H, Kamada T, Arimoto T, et al. The role of radiotherapy in the management of maxillary sinus carcinoma, Cancer, 57 (1986) 2261–2266.
Gadeberg CC, Hjelm-Hausen M, Sogaard H, et al. Malignant tumors of the paranasal sinuses and nasal cavity. A series of 180 patients, Acta Radiol. Oncol., 23 (1984) 181–187.
Rush SE and Bagshaw MA. Carcinoma of the paranasal sinuses, Cancer, 50 (1982) 154–158.
Hordijk GJ and Brons EN. Carcinomas of the maxillary sinus: a retrospective study, Clin. Otolaryngol., 10 (1985) 285–288.
Hu YH, Tu GY, Qi YQ, et al. Comparison of pre-and postoperative radiation in the combined treatment of carcinoma of maxillary sinus, Int. J. Radiat. Oncol. Biol. Phys., 8 (1982) 1045–1049.
Knegt PP, de Jong PC, van Andel JG, et al. Carcinoma of the paranasal sinuses. Results of a prospective pilot study, Cancer, 56 (1985) 57–62.
Lindeman P, Eklund V, and Petruson B. Survival after surgical treatment in maxillary neoplasms of epithelial origin, J. Laryngol. Otol., 101 (1987) 564–568.
Sakai S, Hohki A, Fuchihata H, et al. Multidisciplinary treatment of maxillary sinus carcinoma, Cancer, 52 (1983) 1360–1364.
Schlappack OK, Dobrowsky W, Schratter M, et al. Radiotherapy of carcinoma of the paranasal sinuses, Strahlenter. Oncol., 162 (1986) 291–299.
St. Pierre S and Baker SR. Squamous cell carcinoma of the maxillary sinus: analysis of 66 cases, Head Neck Surg., 5 (1983) 508–513.
Roa WH, Hazuka MB, Sandler HM, et al. Results of primary and adjuvant CT-based 3-dimensional radiotherapy for malignant tumors of the paranasal sinuses, Int. J. Radiat. Oncol. Biol. Phys., 28 (1994) 857–865.
Hong WK, Bromer RH, Amato DA, et al. Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality treatment, Cancer,45 (1985)1242–1249.
Deutsch M, Leen R, Parsons JA, et al. Radiotherapy for postoperative recurrent squamous cell carcinoma in head and neck, Arch. Otolaryngol., 98 (1973) 316–318.
Pearlman NW. Treatment outcome in recurrent head and neck cancer, Arch. Surg., 114 (1979) 39–42.
Emami B, Bignardi M, Devineni VR, et al. Reirradiation of recurrent head and neck cancers, Laryngoscope, 97 (1987) 85–88.
Langlois D, Eschwege F, Kramar A, et al. Reirradiation of head and neck cancers, Radiother. Oncol., 3 (1985) 27–33.
Pomp J, Levendag PC, and van Putten WLJ. Reirradiation of recurrent tumors in the head and neck, Am. J. Clin. Oncol., 11 (1988) 543–549.
Skolyszewski J, Korzeniowski, S, and Reinfuss M. The reirradiation of recurrences of head and neck cancer, Br. J. Radiol., 53 (1980) 462–465.
Stevens KR, Britsch A, and Moss WT. High-dose reirradiation of head and neck cancer with curative intent, Int. J. Radiat. Oncol. Biol. Phys., 29 (1994) 687–698.
Fu KK, Newman H, and Phillips TL. Treatment of locally recurrent carcinoma of the nasopharynx, Radiology, 117 (1975) 425–431.
Nisar Syed AM, Feder BH, George FW, et al. Iridium-192 after loaded implant in the retreatment of head and neck cancer, Br. J. Radiol., 51 (1978) 814–820.
Thompson RW, Scottie Doggett RL, and Bagshaw MA. Ten year experience with linear accelerator irradiation of cancer of nasopharynx, Radiology, 97 (1970) 149–155.
Vokes EE, Haraf DJ, Mick R, et al. Intensified concomitant chemoradiotherapy with and without filgrastim for poor prognosis head and neck cancer, J. Clin. Oncol., 12 (1994) 2351–2359.
Hartsell WF, Thomas CR, Murthy AK, et al. Pilot study for the evaluation of simultaneous cisplatin/ 5-fluorouracil infusion and limited radiation therapy in regionally recurrent head and neck cancer (ESTP-C385), Am. J. Clin. Oncol. (CCT), 17 (1994) 338–343.
Weppelmann B, Wheeler RH, Peters GE, et al. Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation, Int. J. Radiat. Oncol. Biol. Phys.,22 (1992) 10511056.
Spencer S, Wheeler R, Meredith R, et al. Simultaneous hydroxyurea, 5-fluorouracil, and high-dose BID irradiation in previously irradiated patients with recurrent squamous cell cancer of the head and neck, Third International Conference on Head and Neck Cancer, San Francisco, 1992.
Emami B and Marks JE. Retreatment of recurrent carcinoma of the head and neck by afterloading interstitial 192-Ir implant, Laryngoscope, 93 (1983) 1345–1347.
Mazeron JJ, Langlois D, Glaubiger D, et al. Salvage irradiation of oropharyngeal cancers using iridium 192 wire implants: 5-year results of 70 cases, Int. J. Radiat. Oncol. Biol. Phys., 13 (1987) 957–962.
Puthawala AA and Syed AMN. Interstitial reirradiation for recurrent and/or persistent head and neck cancers, Int. J. Radial. Oncol. Biol. Phys., 13 (1987) 1113–1114.
Vikram B and Mishra S Permanent iodine-125 implants in postoperative radiotherapy for head and neck cancer with positive surgical margins, Head Neck, 16 (1994) 155–157.
Fee WE Jr, Goffinet DR, Paryani S, et al. Intraoperative iodine-125 implants: their use in large tumors in the neck attached to the carotid artery, Arch. Otolaryngol. Head Neck Surg., 109 (1983) 727–730.
Kumar PP, Good RR, Yonkers AJ, et al. High activity iodine-125 endocurie therapy for head and neck tumors, Laryngoscope, 99 (1989) 174–178.
Chen KY, Mohr RM, and Silverman CL. Interstitial iodine 125 in advanced recurrent squamous cell carcinoma of the head and neck with follow-up evaluation of carotid artery by ultrasound, Ann. Otol. Rhinol. Laryngol., 105 (1996) 955–961.
Emami B, Marks JE, Perez CA, et al. Interstitial thermoradiotherapy in the treatment of recurrent/ residual malignant tumors, Am. J. Clin. Oncol., 7 (1984) 699–704.
Puthawala AA, Syed AMN, Sheiku KMA, et al. Interstitial hyperthermia for recurrent malignancies. Endocurie Therapy/Hypertherm. Oncol., 1 (1985) 125–131.
Tupchong L, Waterman FM, and McFarlane JD. Hyperthermia and radiation therapy for advanced regional disease due to recurrent head and neck carcinoma, Int. J. Radiat. Oncol. Biol. Phys., 19 (1990) 1099.
Hong WK and Bromer R. Chemotherapy in head and neck cancer, N. Engl. J. Med., 308 (1983) 75–79.
Pryzant RM, Wendt CD, Delclos L, Peters LI, et al. Retreatment of nasopharyngeal carcinoma in 53 patients, Int. J. Radiat. Oncol. Biol. Phys., 22 (1992) 941–947.
Benchalal M, Bachaud JM, Francois P, et al. Hyperfractionation in the reirradiation of head and neck cancer, Results of a pilot study, Radiother. Oncol., 36 (1995) 203–210.
Wang CC. Reirradiation of recurrent nasopharyngeal carcinoma-treatment techniques and results, Int. J. Radiat. Oncol. Biol. Phys., 13 (1987) 953–956.
Lee AWM, Law SCK, Foo W, et al. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976–1985: survival after local recurrence, Int. J. Radiat. Oncol. Biol. Phys., 26 (1993) 773–782.
Levendag PC, Meeuwis CA, and Visser AG. Reirradiation of recurrent head and neck cancers; external and/or interstitial radiation therapy, Radiother. Oncol., 23 (1992) 6–14.
Saroja KR, Hendrickson FR, Cohen L, et al. Reirradiation of locally recurrent tumors with fast neutrons, Int. J. Radiat. Oncol. Biol. Phys., 15 (1988) 115–121.
Housset M, Barrett JM, Brunel P, et al. Split-course interstitial brachytherapy with a source shift: the results of a new technique for salvage irradiation in recurrent inoperable cervical adenopathy 4 cm diameter in 23 patients, Int. J. Radiat. Oncol. Biol. Phys., 22 (1992) 1071–1074.
Langlois D, Hoffstetter S, Malissard L, et al. Salvage irradiation of oropharynx and mobile tongue about 192 iridium brachytherapy in Centre Alexis Vautrin, Int. J. Radiat. Oncol. Biol. Phys., 14 (1988) 849–853.
McCollough KP and Blackwell CR. A dosimetric summary of common bolus materials, (Abstract) Med. Phys., 19 (1992) 835.
Chang F, Chang P, Benson K, et al. Study of Elasto-gel pads used as surface bolus material in high energy photon and electron therapy, Int. J. Radiat. Oncol. Biol. Phys., 22 (1991) 191–193.
Nag S, Schuller D, Pak V, et al. IORT using electron beam or HDR brachytherapy for previously unirradiated head and neck cancers, Front. Radiat. Ther. Oncol., 31 (1997) 112–116.
Nag S, Schuller D, Pak V, Young D, Grecula J, Bauer C, et al. Pilot study of intraoperative high dose rate brachytherapy for head and neck cancer, Radiother. Oncol., 41 (1996) 125–130.
Freeman S, Hamaker R, Singer M, et al. Intraoperative radiotherapy of skull base cancer, Laryngoscope, 101 (1991) 507–509.
Freeman SB, Hamaker RC, Rate WR, et al. Management of advanced cervical metastasis using intra-operative radiotherapy, Laryngoscope, 105 (1995) 575–578.
Garrett PG, Pugh NO, Ross HR, et al. Intraoperative radiation therapy for advanced recurrent head and neck cancer, Int. J. Radiat. Oncol. Biol. Phys., 13 (1987) 785–788.
Garrett PG, Hamaker R, Pugh N, et al. Intraoperative radiation therapy for advanced or recurrent head and neck malignancy. In: First International Symposium on Intraoperative Radiation Therapy, Dobelbower, RR and Abe, M, Boca Raton, FL, CRC (1989).
Garrett P, Rate W, Hamaker R, et al. Intraoperative radiation therapy for advanced or recurrent head and neck malignancies. In: Proceedings of the Third International Symposium on Intraoperative Radiation Therapy, Elmsford, NY, Pergamon (1991).
Garrett PG, Rate W, Hamaker R, et al. Surgical resection and intraoperative radiation therapy (IORT) for advanced or recurrent salivary gland malignancies. In: Fourth International Symposium on Intra-operative Radiation Therapy, 1992, pp. 199–202.
Rate W, Garrett P, Hamaker R, et al. Intraoperative radiation therapy for recurrent head and neck cancer, Cancer, 67 (1991) 2738–2740.
Rate W, Garrett P, Hamaker R, et al. Surgical resection and intraoperative radiation ( IORT) for advanced neck lymph node metastases. Fourth International Symposium on Intraoperative Radiation Therapy, 1992, pp. 203–206.
Foote RL, McCaffrey TV, Olsen KD, et al. Intraoperative electron beam radiation therapy for advanced or recurrent head and neck cancer., Fifth International IORT Symposium, Lyon, France, 1994.
Ling SM, Roach M, Fu KK, et al. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience, Cancer J. Sci. Am., 2 (1996) 321–329.
Martinez-Monge R, Azinovic I, Alcalde J, et al. IORT in the management of locally advanced or recurrent head and neck cancer, Front. Radiat. Ther. Oncol., 31 (1997) 122–125.
Toita T, Nakano M, Takizawa Y, et al. Intraoperative radiation therapy (IORT) for head and neck cancer, Int. J. Radiat. Oncol. Biol. Phys., 30 (1994) 1219–1224.
Schmitt TH, Prades JM, Puel G, et al. IORT for locally advanced oropharyngeal carcinomas with major extension into the tongue base, Front. Radiat. Ther. Oncol., 31 (1997) 117–121.
Schuller DE, Grecula JC, Gahbauer RA, et al. Intensified regimen for advanced head and neck squamous cell carcinoma, Arch. Otolaryngol. Head Neck Surg., 123 (1997) 139–144.
Bachaud JM, Cohen-Jonathan E, Alzieu C, et al. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial, Int. J. Radiat. Oncol. Biol. Phys., 36 (1996) 999–1004.
Jacobs JR, Ahmad K, Casiano R, et al. Implications of positive surgical margins, Laryngoscope, 103 (1993) 64–68.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Foote, R.L. et al. (1999). IORT for Head and Neck Cancer. In: Gunderson, L.L., Willet, C.G., Harrison, L.B., Calvo, F.A. (eds) Intraoperative Irradiation. Current Clinical Oncology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-696-6_26
Download citation
DOI: https://doi.org/10.1007/978-1-59259-696-6_26
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-5576-3
Online ISBN: 978-1-59259-696-6
eBook Packages: Springer Book Archive